Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cleary

Showing results (321-330 of 445) with videos related to

Pageof 45
Sort By:
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case reportDouglas Rubinson, Brian M Wolpin, Ilana S Warsofsky, et al.
Elife|April 8, 2017
Purinergic regulation of vascular tone in the retrotrapezoid nucleus is specialized to support the drive to breatheVirginia E Hawkins, Ana C Takakura, Ashley Trinh, et al.
BMJ (Clinical Research Ed.)|August 28, 2012
Transfer of high cost drugs to NICE risks fragmentation of care of rare diseasesChris J Hendriksz, D A Hughes, A B Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.
Biochemical and Biophysical Research Communications|July 12, 2022
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1Jin-Ah Kim, Noah E Berlow, Melvin Lathara, et al.
Cancer|November 25, 2010
Sunitinib rechallenge in metastatic renal cell carcinoma patientsIvan N Zama, Thomas E Hutson, Paul Elson, et al.
Pediatrics|January 5, 2000
Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trialT E Wiswell, C M Gannon, J Jacob, et al.
Investigational New Drugs|March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFRJames M Cleary, Emiliano Calvo, Victor Moreno, et al.
Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.
Pageof 45

Showing results (321-330 of 445) with videos related to

Sort By:
Pageof 45
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case reportDouglas Rubinson, Brian M Wolpin, Ilana S Warsofsky, et al.
Elife|April 8, 2017
Purinergic regulation of vascular tone in the retrotrapezoid nucleus is specialized to support the drive to breatheVirginia E Hawkins, Ana C Takakura, Ashley Trinh, et al.
BMJ (Clinical Research Ed.)|August 28, 2012
Transfer of high cost drugs to NICE risks fragmentation of care of rare diseasesChris J Hendriksz, D A Hughes, A B Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.
Biochemical and Biophysical Research Communications|July 12, 2022
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1Jin-Ah Kim, Noah E Berlow, Melvin Lathara, et al.
Cancer|November 25, 2010
Sunitinib rechallenge in metastatic renal cell carcinoma patientsIvan N Zama, Thomas E Hutson, Paul Elson, et al.
Pediatrics|January 5, 2000
Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trialT E Wiswell, C M Gannon, J Jacob, et al.
Investigational New Drugs|March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFRJames M Cleary, Emiliano Calvo, Victor Moreno, et al.
Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.
Pageof 45